GUT Recent advances in basic science

Organoids in gastrointestinal diseases: from experimental models to clinical translation

Claudia Günther, Beate Winner, Markus F Neurath, Thaddeus S Stappenbeck

10.1136/gutjnl-2021-326560

May 30, 2022

Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions

Rocio I R Macias, Vincenzo Cardinale, Timothy J Kendall, Matias A Avila, Maria Guido, Cedric Coulouarn, Chiara Braconi, Adam E Frampton, John Bridgewater, Diletta Overi, Stephen P Pereira, Marco Rengo, Jakob N Kather, Angela Lamarca, Federica Pedica, Alejandro Forner, Juan W Valle, Eugenio Gaudio, Domenico Alvaro, Jesus M Banales, Guido Carpino

10.1136/gutjnl-2022-327099

May 17, 2022

Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes

Nick Lung-Ngai Ting, Harry Cheuk-Hay Lau, Jun Yu

10.1136/gutjnl-2021-326264

March 11, 2022

Dietary macronutrients and the gut microbiome: a precision nutrition approach to improve cardiometabolic health

Kelly M Jardon, Emanuel E Canfora, Gijs H Goossens, Ellen E Blaak

10.1136/gutjnl-2020-323715

February 8, 2022

Omega-3 polyunsaturated fatty acids: moving towards precision use for prevention and treatment of colorectal cancer

Joanna Aldoori, Andrew J Cockbain, Giles J Toogood, Mark A Hull

10.1136/gutjnl-2021-326362

February 3, 2022

Gut microbiome and health: mechanistic insights

Willem M de Vos, Herbert Tilg, Matthias Van Hul, Patrice D Cani

10.1136/gutjnl-2021-326789

February 1, 2022

Alternative splicing of viral transcripts: the dark side of HBV

Dina Kremsdorf, Bouchra Lekbaby, Pierre Bablon, Jules Sotty, Jérémy Augustin, Aurélie Schnuriger, Jonathan Pol, Patrick Soussan

10.1136/gutjnl-2021-324554

September 17, 2021

Calprotectin: from biomarker to biological function

Almina Jukic, Latifa Bakiri, Erwin F. Wagner, Herbert Tilg, Timon E. Adolph

10.1136/gutjnl-2021-324855

June 18, 2021

Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?

Anja Rinke, Christoph J Auernhammer, Lisa Bodei, Mark Kidd, Sebastian Krug, Rita Lawlor, Ilaria Marinoni, Aurel Perren, Aldo Scarpa, Halfdan Sorbye, Marianne Ellen Pavel, Matthias M Weber, Irvin Modlin, Thomas M Gress

10.1136/gutjnl-2020-321300

March 10, 2021

From the origin of NASH to the future of metabolic fatty liver disease

Andreas Geier, Dina Tiniakos, Helmut Denk, Michael Trauner

10.1136/gutjnl-2020-323202

February 25, 2021